Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Rapport Therapeutics, Inc. (RAPP) had Normalized Income after Taxes of $-56.62M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-56.62M |
|
-- |
|
-- |
|
$60.81M |
|
$-60.81M |
|
$4.19M |
|
$-56.62M |
|
$-56.62M |
|
$-56.62M |
|
$-56.62M |
|
$-56.62M |
|
|
Normalized Income after Taxes |
$-56.62M |
$-60.81M |
|
$-60.25M |
|
47.47M |
|
47.47M |
|
$-1.19 |
|
$-1.19 |
|
| Balance Sheet Financials | |
$446.86M |
|
$2.34M |
|
$12.13M |
|
$458.98M |
|
$28.42M |
|
-- |
|
$7.63M |
|
$36.06M |
|
$422.93M |
|
$422.93M |
|
$422.93M |
|
47.95M |
|
| Cash Flow Statement Financials | |
$-54.52M |
|
$63.54M |
|
$1.94M |
|
$52.75M |
|
$63.72M |
|
$10.97M |
|
$14.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.72 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-54.49M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-13.39% |
|
-13.39% |
|
-12.33% |
|
-13.39% |
|
$8.82 |
|
$-1.15 |
|
$-1.15 |
|